ARTHROPLASTY
Tranexamic acid reduces blood loss significantly more than fibrin glue following TKA
J Bone Joint Surg Am. 2013 Nov 20;95(22):2001-7172 patients who were scheduled for elective primary total knee arthroplasty were randomly assigned into 1 of 4 groups, 2 fibrin glue groups (Blood and Tissue Bank of Batalonia fibrin glue, and Tissucol Duo) 1 tranexamic acid group, and 1 control (receiving routine hemostasis), to determine if fibrin glue or tranexamic acid significantly reduces blood loss following TKA when compared to routine hemostasis treatment, 120 hours after treatment. The results of the study indicated that neither type of fibrin glue used in the study was more effective than routine hemostasis at reducing postoperative bleeding and transfusions; however, it does support current evidence in finding that intravenous tranexamic acid decreases postoperative blood loss.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
